Magsaam J, Gharavi A E, Parnassa A P, Weissbach H, Brot N, Elkon K B
Hospital for Special Surgery/Cornell University Medical Center, New York, NY 10021.
Clin Exp Immunol. 1989 May;76(2):165-71.
The cDNA encoding the ribosomal protein P2 antigen was cloned from a human cDNA library constructed in the lambda gt11 expression vector. A beta-galactosidase-P2 fusion protein was purified to near homogeneity and used to develop an ELISA which was highly specific for anti-P antibodies produced in murine and human SLE. The median concentration of human IgG anti-P antibodies in serum was estimated to be 100 micrograms/ml (range 6-450 micrograms/ml). Pre-incubation of human anti-P sera with a synthetic peptide, corresponding to the C-terminal 22 amino acids of P2, completely inhibited reactivity with the fusion protein in the ELISA. These findings confirm that lupus anti-P sera show a striking restriction in epitope specificity and indicate that the P2 fusion protein is a useful alternative to the synthetic peptide antigen for detection and quantification of anti-P antibodies. To investigate the possibility that anti-P antibodies were induced by 'altered-self', cDNA encoding P2 were also cloned from lupus patients and control mononuclear cells. The predicted amino acid sequences of the patients' P2 were identical to that of the normal controls indicating that a primary structural abnormality of the P2 autoantigen was unlikely.
编码核糖体蛋白P2抗原的cDNA是从构建于λgt11表达载体的人cDNA文库中克隆得到的。一种β-半乳糖苷酶-P2融合蛋白被纯化至接近均一状态,并用于开发一种酶联免疫吸附测定法(ELISA),该方法对小鼠和人类系统性红斑狼疮(SLE)中产生的抗P抗体具有高度特异性。血清中人IgG抗P抗体的中位浓度估计为100微克/毫升(范围为6 - 450微克/毫升)。用人抗P血清与一种合成肽(对应于P2的C末端22个氨基酸)进行预孵育,可完全抑制ELISA中与融合蛋白的反应性。这些发现证实狼疮抗P血清在表位特异性上表现出显著的局限性,并表明P2融合蛋白是用于检测和定量抗P抗体的合成肽抗原的有用替代品。为了研究抗P抗体是否由“自身改变”诱导,还从狼疮患者和对照单核细胞中克隆了编码P2的cDNA。患者P2的预测氨基酸序列与正常对照相同,这表明P2自身抗原不太可能存在一级结构异常。